|
Comprehensive prevention program helps avoid unintended pregnancy. (Symposia Highlights).
Publication: Skin & Allergy News Publication Date: 01-JAN-02 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2002 International Medical News Group
Clinician and patient adherence to a pregnancy prevention program helps avoid unintended pregnancy in the vast majority of women who use teratogenic dermatologic drugs, results of one manufacturer's program demonstrate.
Data from the Roche Pregnancy Exposure Database show that less than 1% of more than 800,000 women 12 to 49 years of age who were treated with Accutane (isotretinoin) have reported pregnancy just before or during treatment. Most of the pregnancies appeared to be unintended, as more than 90% of the women acknowledged being advised to avoid pregnancy during treatment with isotretinoin.
The pregnancy rate among women included in the database declined from 0.4% in 1989 to 0.3% in 1999 despite increased use of isotretinoin during the same time period.
"This pregnancy rate is far lower than that of...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Skin & Allergy News |
Birth control options varied, effective. (Symposia Highlights).
January 01, 2002
|
Reproductive history elicits patient knowledge, needs. (Symposia Highl...
January 01, 2002
|
Use of teratogenic drugs poses counseling challenges. (Symposia Highli...
January 01, 2002
|
Self-regression holds clue to melanoma therapy. (Common in BCC Too).
January 01, 2002
|
Staining aids diagnosis of spindle cell lesions. (Ulcerated Nodules).
January 01, 2002
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
